TTD | Drug: D0A5SJ

Drug General Information
Drug ID	D0A5SJ
Former ID	DNCL002644
Drug Name	B-cell lymphoma vaccine
Synonyms	BiovaxID (TN)
Drug Type	Vaccine
Indication	Indolent follicular lymphoma [ICD9: 202.0, 202.8; ICD10:C81-C86, C82]		Preregistration	[546162]
Company	BioVest International
Target and Pathway
Target(s)	Granulocyte-macrophage colony-stimulating factor receptor alpha chain	Target Info		[549981]
KEGG Pathway	Cytokine-cytokine receptor interaction
	Jak-STAT signaling pathway
	Hematopoietic cell lineage
	Pathways in cancer
NetPath Pathway	IL3 Signaling Pathway
NetPath Pathway	RANKL Signaling Pathway
Pathway Interaction Database	GMCSF-mediated signaling events
Pathway Interaction Database	Alpha9 beta1 integrin signaling events
Reactome	GPVI-mediated activation cascade
	G beta:gamma signalling through PI3Kgamma
	Interleukin-3, 5 and GM-CSF signaling
	RAF/MAP kinase cascade
	Surfactant metabolism
	Interleukin receptor SHC signaling
WikiPathways	Interleukin-2 signaling
WikiPathways	Interleukin-3, 5 and GM-CSF signaling
References
Ref 546162	Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800006688)
Ref 549981	Idiotypevaccinetherapy (BiovaxID) infollicularlymphomain first complete remission: Phase III clinical trial results, Journal of Clinical Oncology, Vol 27, No 18S (June 20 Supplement), 2009: 2.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.

Drug Information